cobas 6000 Core Unit
Total Payments
$2.9M
Transactions
73
Doctors
25
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $9,860 | 5 | 5 |
| 2023 | $613,215 | 11 | 0 |
| 2022 | $956,710 | 15 | 3 |
| 2021 | $1.3M | 42 | 18 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 38 | 97.3% |
| Consulting Fee | $56,518 | 14 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,329 | 8 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $2,500 | 1 | 0.1% |
| Food and Beverage | $669.04 | 12 | 0.0% |
Payments by Type
Research
$2.8M
38 transactions
General
$78,016
35 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RD004723 | Roche Diagnostics Corporation | $617,324 | 0 |
| RD003707 | Roche Diagnostics Corporation | $386,969 | 0 |
| RD005196 | Roche Diagnostics Corporation | $333,398 | 0 |
| Longitudinal Early-onset AD Study (LEADS) | Roche Diagnostics Corporation | $265,278 | 0 |
| RD005665 | Roche Diagnostics Corporation | $247,919 | 0 |
| Comparison of the Elecsys HCV Duo Assay with cobas HCV Nucleic Acid and Elecsys HCV II Antibody Testing | Roche Diagnostics Corporation | $105,267 | 0 |
| RD005686 | Roche Diagnostics Corporation | $98,222 | 0 |
| RD005909 | Roche Diagnostics Corporation | $93,608 | 0 |
| RD006556 | Roche Diagnostics Corporation | $73,283 | 0 |
| CSF AD Markers in Health and Disease | Roche Diagnostics Corporation | $66,512 | 0 |
| RD003152: AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke | Roche Diagnostics Corporation | $64,870 | 0 |
| RD003017: High-Sensitivity Cardiac Troponin T to Optimize Chest Pain Risk Stratification (STOP CP) | Roche Diagnostics Corporation | $54,432 | 0 |
| RD005671 | Roche Diagnostics Corporation | $47,521 | 0 |
| RD003708: Utilization of procalcitonin and IL-6 as biomarkers to diagnose newborn sepsis | Roche Diagnostics Corporation | $46,857 | 0 |
| RD005669 | Roche Diagnostics Corporation | $36,660 | 0 |
| RD003699 | Roche Diagnostics Corporation | $21,475 | 0 |
| RMJ20 | Roche Diagnostics Operations, Inc. | $16,990 | 0 |
| RD005866 | Roche Diagnostics Corporation | $11,925 | 0 |
| RD3764: Primary HPV-testing using Cobas: A cost-effective strategy for cervical cancer screening in Puerto Rican women | Roche Diagnostics Corporation | $10,000 | 0 |
| RD003708 | Roche Diagnostics Corporation | $9,891 | 0 |
Top Doctors Receiving Payments for cobas 6000 Core Unit
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $2.8M | 39 |
| Sarosh Rana | Maternal & Fetal Medicine | Chicago, IL | $20,405 | 3 |
| , M.D | Obstetrics | San Diego, CA | $16,725 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | Boston, MA | $10,750 | 1 |
| , M.D | Obstetrics & Gynecology | Houston, TX | $7,500 | 2 |
| , M.D., PH.D | Medical Microbiology | Nashville, TN | $3,345 | 1 |
| , M.D | Cardiovascular Disease | San Diego, CA | $3,150 | 2 |
| , MD PHD | Clinical Pathology/Laboratory Medicine | Boston, MA | $2,503 | 1 |
| Peter Mccaffrey | Anatomic Pathology | Galveston, TX | $2,455 | 1 |
| , M.D., M.P.H | Emergency Medicine | San Diego, CA | $2,173 | 1 |
| , M.D | Obstetrics & Gynecology | Palo Alto, CA | $2,000 | 1 |
| , CRNP | Nurse Practitioner | Harrisburg, PA | $1,493 | 1 |
| , M.D., MBA | Emergency Medicine | Boston, MA | $790.00 | 1 |
| , M.D., PHD | Student in an Organized Health Care Education/Training Program | Minneapolis, MN | $753.00 | 3 |
| , MD | Emergency Medicine | La Jolla, CA | $630.00 | 1 |
| , CRNA | Nurse Anesthetist, Certified Registered | Duluth, MN | $191.78 | 3 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Nashville, TN | $175.00 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | West Hollywood, CA | $162.11 | 1 |
| , M.D | Emergency Medicine | Winston Salem, NC | $120.48 | 1 |
| , M.D | Obstetrics & Gynecology | Caguas, PR | $75.00 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Gainesville, FL | $40.26 | 1 |
| , DO | Anatomic Pathology | Louisville, KY | $29.05 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Munster, IN | $13.06 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Munster, IN | $13.06 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Munster, IN | $13.05 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $2.9M
- Total Doctors 25
- Transactions 73
About cobas 6000 Core Unit
cobas 6000 Core Unit is a device associated with $2.9M in payments to 25 healthcare providers, recorded across 73 transactions in the CMS Open Payments database. The primary manufacturer is Roche Diagnostics Corporation.
Payment data is available from 2021 to 2024. In 2024, $9,860 was paid across 5 transactions to 5 doctors.
The most common payment nature for cobas 6000 Core Unit is "Unspecified" ($2.8M, 97.3% of total).
cobas 6000 Core Unit is associated with 20 research studies, including "RD004723" ($617,324).